# Electroacupuncture Combined With Immune Checkpoint Inhibitors as Adjuvant Therapy After Surgery for Early-stage Non-small Cell Lung Cancer

Source: https://onco.cc/trials/nct07034326/  
OnCo record `nct07034326` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2/3 trial in lung cancer, run by Kong Fanming, now recruiting.

## Summary

Electroacupuncture Combined With Immune Checkpoint Inhibitors as Adjuvant Therapy After Surgery for Early-stage Non-small Cell Lung Cancer is a phase 2/3, randomised interventional study registered as NCT07034326 by Kong Fanming, with a registry enrolment figure of 405 participants, started 2025-01-01 and due to reach its primary completion in 2028-12-31. Interventions recorded: Electroacupuncture combined with immunotherapy; Zilongjin tablet combined with immunotherapy; Immunotherapy. Conditions listed: Non-Small Cell Lung Cancer; Electroacupuncture; Immune Checkpoint Inhibitors. Primary outcome: Disease free survival(DFS). Lung eligibility wording from the registry: "* (1) Non-tumor patients with stage II, IIIA, IIIB (N2) non-small cell lung cancer diagnosed by pathology or cytology after surgery; (2) driver mutations negative patients; (3) Postoperative adjuvant chemotherapy was received for 1 to 4 cycles;(4)conforms to two qi syndrome of traditional Chinese me". Sites: China. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-25
- Tags: ctgov-ingest; lung-deep-dive
- Registry id: NCT07034326
- Phase: 2/3
- Setting: Observation on the Clinical Efficacy of Electroacupuncture Combined With Immune Checkpoint Inhibitors as Adjuvant Therapy After Surgery for Early-stage Non-small Cell Lung Cancer
- Sponsor: Kong Fanming
- Enrolled: 405

## Sources

- ClinicalTrials.gov NCT07034326: https://clinicaltrials.gov/study/NCT07034326

## Connected records

- cancers: [Resectable stage I to III non-small-cell lung cancer](https://onco.cc/cancers/resectable-nsclc/)
- terms: [Lung cancer trials open today (registry snapshot)](https://onco.cc/terms/lung-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct07034326.json